Advanced search
Search Results: 30 results for keyword "Imexpharm".
SK Investment Vina III to hold 65 per cent of Imexpharm
28-12-2023 11:20
SK Investment Vina III Pte. Ltd (SK Vina III), a subsidiary of South Korea’s third-largest conglomerate SK Group, aims to hold a 65 per cent stake in Imexpharm Pharmaceutical JSC (IMP).
Imexpharm honoured as top 5 company with best working environment in Vietnam
30-11-2023 14:05
Imexpharm Pharmaceutical JSC has been named in the top 5 companies with the best working environment in Vietnam for pharmaceuticals, medical devices, and healthcare companies in the medium-sized enterprise category.
Imexpharm raises its status with EU-GMP-standard factories
25-11-2023 17:38
Operating the largest pharmaceutical production lines that meet European standards (EU-GMP) in Vietnam, Imexpharm has great potential to become a leading pharmaceutical enterprise. These advantages are also shown through the company's impressive business results.
Imexpharm making inroads in achieving sustainable efficiency
01-03-2022 18:00
After four decades of development, Imexpharm Corporation has reaffirmed its position as a market leader in Vietnam’s pharmaceutical industry by investing in sustainable technology and human resources.
Imexpharm Corporation reports dropping revenue during social distancing
23-09-2021 08:00
In August, Imexpharm Corporation recognised a decrease of 12 per cent in revenue and 14 per cent in profit due to social distancing.
SK Investment Vina raises ownership to 29.2 per cent in Imexpharm
15-06-2021 20:43
SK Investment Vina III Pte., Ltd. has spent over VND34.5 billion ($1.5 million) to acquire 3.4 million shares of Imexpharm Pharmaceutical JSC to raise its ownership at the firm to 29.22 per cent.
Targets being tweaked by prepared pharma
09-06-2021 20:53
There remains caution over interruption in the ingredient supply chain in Vietnam’s lucrative pharmaceutical industry, but new strategies to intensify growth potential ahead will ensure pharma groups maintain their profitability moving forward.
Imexpharm secures loan from ADB to support generic medicine production
16-12-2020 11:55
The Asian Development Bank (ADB) signed an $8 million loan with Imexpharm Corporation to help the company sustain its production of generic medicines, despite global supply disruptions caused by the COVID-19 pandemic.
SK Group acquires 25 per cent of Imexpharm
01-06-2020 14:44
South Korean conglomerate SK Group has become a large shareholder of Imexpharm (IMP), adding to its considerable portfolio of shares in Vingroup, Masan, and PV Oil.
Pharma firms expect hike in revenue thanks to COVID-19
07-04-2020 19:06
A bit of a silver lining to the COVID-19 lockdown, major pharma firms expect to see visible growth in revenue this year.
Imexpharm continues to push limits of possibility
24-02-2020 14:00
As Vietnam has become an emerging pharmaceutical market, Imexpharm is eager to invest in innovation and technology to capitalise on rising healthcare demand.
Imexpharm may scrap FOL if market winds are right
05-09-2017 17:45
Imexpharm Pharmaceutical Joint Stock Company, Vietnam's fourth-biggest pharmaceutical firm, will consider scrapping the foreign ownership limit if this becomes a common trend.
Imexpharm terminates distribution contract with IMGSA Group
29-07-2017 18:24
Imexpharm Pharmaceutical Joint Stock Company, Vietnam's fourth biggest pharmaceutical firm, will not extend the distribution contract with its foreign partner IMGSA Group in the future.
Pharmas keep foreign cap
16-05-2016 08:00
While Vietnam’s third-largest domestic drug maker Domesco has agreed to remove the foreign ownership ratio ceiling, other leading domestic pharmaceutical firms, including Imexpharm and Hau Giang Pharmaceutical JSC, have again announced no change to the cap.
Imexpharm prevails against accusations
14-05-2013 10:29
Locally-owned pharmaceutical maker Imexpharm Corporation has successfully defended itself after the Government Inspectorate accused it of violating medicine material trading regulations - but the case still damaged its reputation, company officers say.
Mobile Version